Skip to main content
. 2022 Nov-Dec;38(8):2215–2219. doi: 10.12669/pjms.38.8.5732

Table-IV.

Comparison of adverse reactions [n (%)].

Group n Allergy Rashes Vomiting Constipation Total incidence
Treatment group 34 0 (0.00) 0 (0.00) 1 (2.94) 0 (0.00) 1 (2.94)
Control group 34 0 (0.00) 1 (2.94) 1 (2.94) 1 (2.94) 3 (8.82)
x2 - 1.063
P - 0.303